Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
出版年份 2013 全文链接
标题
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
作者
关键词
-
出版物
OncoImmunology
Volume 2, Issue 8, Pages e26218
出版商
Informa UK Limited
发表日期
2013-09-21
DOI
10.4161/onci.26218
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
- (2013) Eric O. Long et al. Annual Review of Immunology
- Levels of peripheral CD4+FoxP3+ regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer
- (2012) X. Yao et al. BLOOD
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
- (2012) Dean A. Fennell et al. Journal of Thoracic Oncology
- A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma
- (2012) Anna K. Nowak et al. Journal of Thoracic Oncology
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence
- (2012) Cheng Sun et al. PLoS Pathogens
- Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the c cytokines and TGF- 1
- (2011) Y. P. Park et al. BLOOD
- Immunologic biomarkers as correlates of clinical response to cancer immunotherapy
- (2011) Mary L. Disis CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antibody Targeting of TGF-β in Cancer Patients
- (2011) Scott Lonning et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
- (2011) Howard Trachtman et al. KIDNEY INTERNATIONAL
- Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey
- (2011) P.A. Zucali et al. LUNG CANCER
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity
- (2011) Erica B. Wilson et al. PLoS One
- TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells
- (2011) Dat Q. Tran Journal of Molecular Cell Biology
- Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens
- (2010) O. Marina et al. CANCER RESEARCH
- Enhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitor
- (2010) Yukimi Taniguchi et al. CANCER SCIENCE
- Cellular and molecular basis for the regulation of inflammation by TGF-
- (2010) A. Yoshimura et al. JOURNAL OF BIOCHEMISTRY
- A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
- (2010) Sarita Dubey et al. Journal of Thoracic Oncology
- Therapeutic Cancer Vaccines in Prostate Cancer: The Paradox of Improved Survival Without Changes in Time to Progression
- (2010) R. A. Madan et al. ONCOLOGIST
- Synergistic Enhancement of CD8+ T Cell-Mediated Tumor Vaccine Efficacy by an Anti-Transforming Growth Factor- Monoclonal Antibody
- (2009) M. Terabe et al. CLINICAL CANCER RESEARCH
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- The TGF-β paradox in human cancer: an update
- (2009) Maozhen Tian et al. Future Oncology
- Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
- (2009) Diana Llopiz et al. INTERNATIONAL JOURNAL OF CANCER
- Disruption of TGF- Signaling Prevents the Generation of Tumor-Sensitized Regulatory T Cells and Facilitates Therapeutic Antitumor Immunity
- (2009) U. Petrausch et al. JOURNAL OF IMMUNOLOGY
- Protein disulfide isomerases are antibody targets during immune-mediated tumor destruction
- (2008) C. Fonseca et al. BLOOD
- Systemic Blockade of Transforming Growth Factor- Signaling Augments the Efficacy of Immunogene Therapy
- (2008) S. Kim et al. CANCER RESEARCH
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Transforming Growth Factor- Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
- (2008) A. Wallace et al. CLINICAL CANCER RESEARCH
- The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
- (2008) Justin Stebbing et al. LUNG CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now